OpenBiome No Longer Distributing FMT For Recurrent C. difficile Infections (GI & Endoscopy News)

OpenBiome, a prominent nonprofit stool bank, has voluntarily suspended the distribution of investigational fecal microbiota transplantation (FMT) preparations for treating recurrent Clostridioides difficile infections (CDI). This suspension, effective September 29, 2024, limits practitioners to FDA-approved FMT products for such cases. OpenBiome will continue supplying FMT preparations for severe fulminant CDIs, including pediatric patients, only through the end of 2024.